|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.110 HKD | +2.89% |
|
+8.05% | +15.05% |
| 06:07am | Sino Biopharm To Remain Active in M&A, Says Chair | MT |
| 01:02am | Sino Biopharm Shares Jump After Plan to Acquire Hygieia | DJ |
| Capitalization | 114B 127B 16.3B 13.99B 13.02B 12.12B 22.62B 1,472B 24.38B 150B 58.91B 704B 61.13B 59.87B 2,579B | P/E ratio 2025 * |
25.6x | P/E ratio 2026 * | 24.4x |
|---|---|---|---|---|---|
| Enterprise value | 108B 120B 15.43B 13.24B 12.33B 11.47B 21.41B 1,393B 23.08B 142B 55.76B 666B 57.87B 56.68B 2,442B | EV / Sales 2025 * |
3.26x | EV / Sales 2026 * | 2.82x |
| Free-Float |
51.86% | Yield 2025 * |
1.31% | Yield 2026 * | 1.35% |
| 1 day | +2.89% | ||
| 1 week | +8.05% | ||
| Current month | +15.05% | ||
| 1 month | +4.56% | ||
| 3 months | -8.85% | ||
| 6 months | +19.90% | ||
| Current year | +15.05% |
| 1 week | 6.7 |  | 7.29 |
| 1 month | 6.13 | | 7.29 |
| Current year | 6.18 | | 7.29 |
| 1 year | 2.67 | | 9.12 |
| 3 years | 2.29 | | 9.12 |
| 5 years | 2.29 | | 9.69 |
| 10 years | 2.05 | | 11.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
S Y Tse
CEO | Chief Executive Officer | 30 | 2022-07-27 |
Chun Ling Li
DFI | Director of Finance/CFO | 55 | 1995-12-31 |
Hsin Tse
IRC | Investor Relations Contact | 56 | 2013-04-24 |
| Director | Title | Age | Since |
|---|---|---|---|
Ping Tse
CHM | Chairman | 74 | 2000-02-01 |
Hsin Tse
BRD | Director/Board Member | 56 | 1995-07-31 |
| Director/Board Member | 61 | 2017-04-09 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -19.71% | 2.4% | 0 M€ | |
| -3.45% | 0.82% | 0 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.89% | +8.05% | +149.47% | +42.48% | 15.84B | |
| -0.67% | -3.51% | +43.53% | +198.87% | 964B | |
| +2.22% | +5.17% | +50.76% | +26.61% | 515B | |
| +0.19% | -5.33% | +25.87% | +44.59% | 390B | |
| +0.94% | +1.74% | +30.64% | +16.80% | 363B | |
| +2.41% | +0.86% | +34.96% | +22.87% | 292B | |
| +2.13% | +2.17% | +28.80% | +34.61% | 272B | |
| +2.06% | +1.60% | +10.73% | -0.10% | 269B | |
| -1.32% | +3.23% | -36.14% | -20.59% | 265B | |
| +1.02% | -4.22% | +22.50% | +21.45% | 175B | |
| Average | +1.09% | +1.71% | +36.11% | +38.76% | 352.09B | |
| Weighted average by Cap. | +0.66% | +1.58% | +30.38% | +69.30% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 33.01B 36.91B 4.73B 4.06B 3.78B 3.52B 6.57B 427B 7.08B 43.49B 17.11B 204B 17.75B 17.39B 749B | 36.04B 40.3B 5.17B 4.44B 4.13B 3.84B 7.17B 467B 7.73B 47.48B 18.68B 223B 19.39B 18.99B 818B |
| Net income | 4.73B 5.29B 679M 582M 542M 505M 941M 61.26B 1.01B 6.23B 2.45B 29.3B 2.54B 2.49B 107B | 4.71B 5.27B 675M 579M 540M 502M 937M 60.96B 1.01B 6.2B 2.44B 29.16B 2.53B 2.48B 107B |
| Net Debt | -6.06B -6.78B -869M -746M -694M -646M -1.21B -78.46B -1.3B -7.98B -3.14B -37.53B -3.26B -3.19B -138B | -12.1B -13.53B -1.74B -1.49B -1.39B -1.29B -2.41B -157B -2.6B -15.94B -6.27B -74.94B -6.51B -6.37B -275B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-14 | 7.110 $ | +2.89% | 151,467,461 |
| 26-01-13 | 6.910 $ | +0.88% | 130,333,000 |
| 26-01-12 | 6.850 $ | +0.29% | 75,463,750 |
| 26-01-09 | 6.830 $ | +0.74% | 93,024,440 |
| 26-01-08 | 6.780 $ | -0.73% | 56,568,220 |
Delayed Quote Hong Kong S.E., January 14, 2026 at 03:08 am EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 1177 Stock
Select your edition
All financial news and data tailored to specific country editions
